Total Payments
$2,840
2024 Payments
$1,803
Companies
23
Transactions
116
Medicare Patients
528
Medicare Billing
$50,968
Payment Breakdown by Category
Food & Beverage$2,840 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,840 | 116 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $819.60 | 46 | $0 (2024) |
| Axonics, Inc. | $255.06 | 4 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $233.69 | 10 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $219.01 | 10 | $0 (2024) |
| Intra-Sana Laboratories | $180.68 | 2 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $124.09 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $123.97 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $115.31 | 7 | $0 (2024) |
| Fresenius Kabi USA, LLC | $99.51 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $93.86 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,803 | 73 | ABBVIE INC. ($367.79) |
| 2023 | $936.77 | 39 | AbbVie Inc. ($372.92) |
| 2022 | $100.14 | 4 | ABBVIE INC. ($78.89) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.33 | General |
| Category: GI | ||||||
| 12/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/12/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $124.09 | General |
| Category: Immunology | ||||||
| 12/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.83 | General |
| Category: GI | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/26/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.31 | General |
| Category: GI | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: LIVER DISEASE | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/11/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.36 | General |
| Category: GI | ||||||
| 11/07/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: CRITICAL CARE | ||||||
| 11/05/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: LIVER DISEASE | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 354 | 360 | $190,154 | $33,697 |
| 2022 | 7 | 174 | 178 | $104,703 | $17,271 |
Total Patients
528
Total Services
538
Medicare Billing
$50,968
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $48,000 | $5,515 | 11.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 27 | 27 | $35,478 | $5,493 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 53 | $13,401 | $4,924 | 36.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 32 | $8,000 | $3,137 | 39.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 34 | $30,334 | $2,685 | 8.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $9,521 | $2,595 | 27.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $13,640 | $2,393 | 17.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $16,830 | $2,381 | 14.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $6,088 | $2,305 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 31 | $4,737 | $2,080 | 43.9% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 55 | 55 | $4,125 | $189.65 | 4.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 32 | 32 | $41,600 | $6,625 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $6,050 | $3,050 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 25 | $5,625 | $2,662 | 47.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 26 | 28 | $28,000 | $1,917 | 6.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $18,400 | $1,834 | 10.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,328 | $1,027 | 44.1% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 35 | 36 | $2,700 | $157.50 | 5.8% |
About Dr. Abdul Bhutta, MD
Dr. Abdul Bhutta, MD is a Gastroenterology healthcare provider based in Kissimmee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1417268566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abdul Bhutta, MD has received a total of $2,840 in payments from pharmaceutical and medical device companies, with $1,803 received in 2024. These payments were reported across 116 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,840).
As a Medicare-enrolled provider, Bhutta has provided services to 528 Medicare beneficiaries, totaling 538 services with total Medicare billing of $50,968. Data is available for 2 years (2022–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Kissimmee, FL
- Active Since 06/23/2010
- Last Updated 11/18/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1417268566
Products in Payments
- SKYRIZI (Biological) $320.22
- RINVOQ (Biological) $309.68
- Axonics (Device) $255.06
- Linzess (Drug) $233.69
- VOQUEZNA (Drug) $219.01
- RELTONE 200 MG (Drug) $180.68
- TREMFYA (Drug) $146.72
- ZENPEP (Drug) $117.48
- XIFAXAN (Drug) $108.43
- MYRISK (Device) $86.09
- DUPIXENT (Biological) $85.96
- ENTYVIO (Biological) $83.93
- IDACIO (Biological) $77.35
- VIBERZI (Drug) $68.73
- OCALIVA (Drug) $65.62
- RESMETIROM (Drug) $56.76
- CREON (Drug) $55.92
- LINZESS (Drug) $51.52
- STELARA (Biological) $50.27
- OMVOH (Drug) $39.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Kissimmee
Muhammad Mohiuddin, M.d, M.D
Gastroenterology — Payments: $31,603
Gastroenterology $31,603
Basher Atiquzzaman, M.d, M.D
Gastroenterology — Payments: $12,502
Gastroenterology $12,502
Celia Quinnonez, Md, MD
Gastroenterology — Payments: $8,430
Gastroenterology $8,430
Jaime Rivera, M.d, M.D
Gastroenterology — Payments: $3,716
Gastroenterology $3,716
Dr. Seela Ramesh, M.d, M.D
Gastroenterology — Payments: $2,414
Gastroenterology $2,414
Dr. Charles Bisogno, D.o, D.O
Gastroenterology — Payments: $1,505
Gastroenterology $1,505